Who owns Corvus Pharmaceuticals, Inc.?
Institutional ownership of CRVS from SEC Form 13F filings across 119 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
119
13F holders
$453.9M
value, 2026 filers
40.7%
of shares outstanding (34.3M sh)
32
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of CRVS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7.1M | $106.7M | 0.0% | 8.5% | +15.9% |
| 2 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.8M | $56,611 | 0.0% | 4.5% | +29.9% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | $49.2M | 0.0% | 3.9% | -49.1% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 2.7M | $40.8M | 0.0% | 3.2% | +17.8% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $27.7M | 0.0% | 2.2% | +8.2% |
| 6 | GOLDMAN SACHS GROUP INC | 1.6M | $23.6M | 0.0% | 1.9% | +2.3% |
| 7 | MORGAN STANLEY | 1.3M | $20.1M | 0.0% | 1.6% | -46.2% |
| 8 | MILLENNIUM MANAGEMENT LLC | 1.0M | $15.7M | 0.0% | 1.2% | +21.0% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 814,750 | $12.2M | 0.0% | 1% | +21.6% |
| 10 | TWO SIGMA INVESTMENTS, LP | 785,208 | $11.7M | 0.0% | 0.9% | +45.4% |
| 11 | BANK OF AMERICA CORP /DE/ | 757,798 | $11.3M | 0.0% | 0.9% | +219.7% |
| 12 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $11.2M | 0.0% | 0.9% | 0.0% |
| 13 | Blue Owl Capital Holdings LP | 608,600 | $9.1M | 1.4% | 0.7% | +11.7% |
| 14 | NORTHERN TRUST CORP | 575,158 | $8.6M | 0.0% | 0.7% | +13.6% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 520,528 | $7.8M | 0.0% | 0.6% | +3.2% |
| 16 | CITADEL ADVISORS LLC | 397,951 | $5.9M | 0.0% | 0.5% | -10.1% |
| 17 | UBS Group AG | 396,116 | $5.9M | 0.0% | 0.5% | +37.0% |
| 18 | BARCLAYS PLC | 315,749 | $4.7M | 0.0% | 0.4% | +29.5% |
| 19 | Jump Financial, LLC | 313,400 | $4.7M | 0.0% | 0.4% | +112.0% |
| 20 | Polymer Capital Management (HK) LTD | 263,662 | $3.9M | 0.2% | 0.3% | +43.9% |
| 21 | Brevan Howard Capital Management LP | 250,291 | $3.7M | 0.0% | 0.3% | +49.0% |
| 22 | SEB Asset Management AB | 226,837 | $3.4M | 0.0% | 0.3% | 0.0% |
| 23 | VICTORY CAPITAL MANAGEMENT INC | 220,761 | $3.3M | 0.0% | 0.3% | +72.0% |
| 24 | Connor, Clark & Lunn Investment Management Ltd. | 217,750 | $3.3M | 0.0% | 0.3% | +159.5% |
| 25 | Sixth Street Partners Management Company, L.P.NEW | 208,119 | $3.1M | 0.5% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.